[ CancerWeb Home
| Comments
| CancerWeb Report Index ]
The CancerWeb Report, What's New In Cancer: September, 1996
Colorectal Cancer
Last modified on:
Tuesday, April 20, 1999 13:05:02
Copyright © 1994-2008, Information Ventures, Inc.
- The role of screening and surveillance - The topic of screening
and surveillance for colorectal cancer was discussed in a very
readable review in the June, 1996 issue of the Journal of Investigative
Medicine. Between 80 and 85% of colorectal cancers are sporadic.
The remaining 15-20% are hereditary, falling in the categories of
hereditary nonpolyposis colon cancer, familial adenomatous
polyposis (inherited tendency to polyps in the colon), and
Gardner's and Turcot's syndromes. What is now known is that the
more common sporadic cancers also start as polyps, protruding
outgrowths of the colon wall, which grow and years later may
become malignant. It is those polyps which grow to a large size
(over about « inch) that are most prone to becoming malignant.
Polyps are rare below the age of 50, occurring in only 5-10% of
the population, but the incidence increases sharply after that.
This is one reason why the procedure of sigmoidoscopy is
recommended for those over this age. Use of sigmoidoscopy
reduced mortality by 59% and 79% in two studies. Tests for blood
in the stools should start at age 40, and although these tests
are not highly reliable because not all early colon cancers
bleed, five studies in different countries showed that the tests
increase by between 5 and 100% the number of cancers found at an
early operable stage. Colonoscopy, a complete examination of the
colon under anesthesia by a longer viewing instrument than that
used for sigmoidoscopy, is only recommended for those known to
have a tendency to form polyps whether by heredity or as shown by
previous findings of such polyps during sigmoidoscopy, those with
a history of successfully operated colon cancer, and those with
chronic ulcerative colitis of more than 8 years duration. Newer
tests are being developed based on various genetic features and
mutations, and it may eventually be feasible to measure such
special features in cells shed from the colon and found in the
stools. (Westergaard, J Investigative Med 44:216, 1996)

Copyright (c) 1994-2008, Information Ventures, Inc.
Mail us at: Customer-Service@infoventures.com
http://infoventures.com